2020
DOI: 10.1111/jfbc.13405
|View full text |Cite
|
Sign up to set email alerts
|

Isobavachalcone ameliorates diabetic nephropathy in rats by inhibiting the NF‐κB pathway

Abstract: Isobavachalcone (ISO) exhibits good anti‐inflammatory activity. We evaluated the renoprotective effects of ISO against diabetic nephropathy (DN). Diabetic rats established by the single injection of streptozotocin (STZ) were orally treated with ISO. The levels of serum creatinine (Scr), blood urea nitrogen (BUN), and 24 hr urinary protein were measured. In this study, ISO effectively ameliorated renal damage by reducing BUN, Scr, and 24 hr urinary protein and also improved kidney pathological appearances. ISO … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 24 publications
0
6
0
Order By: Relevance
“…NF-κB originating from inflammatory response activation stimulates the induction of IL-6 and MCP-1 secretion, which in turn activates IκB kinase complexes (IKKs). IKKs phosphorylate the serine of the IκB subunit regulatory site of the trimeric p50/p65/IκB, resulting in ubiquitination modification of the IκB subunit, the degradation by proteases, and subsequent release of p50/ p65 and nuclear translocation to the κB site on the corresponding target gene to regulate gene transcription [14][15][16][17]. IL-6 and MCP-1 can activate a large number of inflammatory cells, and the resulting inflammatory cascade amplification is associated with distant organ damages, which positively regulates the activation of NF-κB and aggravates the damage to the intracellular and basement membranes, thereby eliciting proteinuria.…”
Section: Discussionmentioning
confidence: 99%
“…NF-κB originating from inflammatory response activation stimulates the induction of IL-6 and MCP-1 secretion, which in turn activates IκB kinase complexes (IKKs). IKKs phosphorylate the serine of the IκB subunit regulatory site of the trimeric p50/p65/IκB, resulting in ubiquitination modification of the IκB subunit, the degradation by proteases, and subsequent release of p50/ p65 and nuclear translocation to the κB site on the corresponding target gene to regulate gene transcription [14][15][16][17]. IL-6 and MCP-1 can activate a large number of inflammatory cells, and the resulting inflammatory cascade amplification is associated with distant organ damages, which positively regulates the activation of NF-κB and aggravates the damage to the intracellular and basement membranes, thereby eliciting proteinuria.…”
Section: Discussionmentioning
confidence: 99%
“…In vitro, ISO reduces Aβ42 aggregation in SH-SY5Y cells 60 and the tumor necrosis factor-α (TNFα)-induced atrophy of C2C12 myotubes 61 . In rodents, ISO attenuates Parkinson's disease induced by the toxin 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) 62 , sephadexinduced lung injury 63 , as well as streptozotocin-induced diabetic nephropathy 64 . This suggests that ISO has a wide range of cytoprotective effects that might be explained by its autophagy-inducing activity.…”
Section: Discussionmentioning
confidence: 99%
“…N = 8 mice each group. To establish a mouse model of DN, 60 mg/kg streptozotocin (STZ; Sigma-Aldrich, USA) in 0.01 M citrate buffer was intraperitoneally injected into the mice for 5 consecutive days [ 26 ]. Mice in the sham group were injected with the same amount of citrate buffer.…”
Section: Methodsmentioning
confidence: 99%